Company / SG&A per Share
Larimar Therapeutics, Inc. SG&A per Share History
FY2014-FY2019 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$0.33
FY2019
5-year range
$0.18 / $0.70
FY2015-FY2019
Trend
-51.0%
vs FY2018
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $0.70 to $0.33 over the past 2 years.
Based on SEC 10-K filings.
0.33 in FY2019 with a 5-year CAGR of -36.2%.
Improved from $0.70 to $0.33 over the past 2 years.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- +3.0%
- 5-Year CAGR
- -36.2%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2019, sg&a per share decreased 51.0% year-over-year.
- Peak sg&a per share was recorded in FY2014.
- Lowest sg&a per share in the period was in FY2015.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -4.64 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2019 | $0.33 | -51.0% |
| FY2018 | $0.67 | -5.3% |
| FY2017 | $0.70 | +135.0% |
| FY2016 | $0.30 | +62.1% |
| FY2015 | $0.18 | -94.0% |
| FY2014 | $3.08 | - |
As of FY2019 · SEC 10-K · Updated Jun 24, 2026